- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06818877
Training Upper Limbs of Neurodiverse Children by Connecting Brain Activities to a Virtual Reality Based Game
Enhancing Upper Extremity Rehabilitation in Neurodiverse Children: Brain-Computer Interface Mediated Neurofeedback and Virtual Reality for Improved Engagement and Training Quality
This study is testing ways to help children with cerebral palsy (CP) improve how their hands work. Investigators want to see if brain activity using a virtual reality (VR) program can make their hands work better. The program is called Hand and Bimanual Intensive Therapy Virtual Reality (HABIT-VR). Investigators will compare how well HABIT-VR works to a simple VR program.
In the study a VR game will be played and participants in the treatment group, will have hand muscles gently stimulated to help the joints move.
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ahad Behboodi, PhD
- Phone Number: 402-554-7525
- Email: abehboodi@unomaha.edu
Study Locations
-
-
Nebraska
-
Omaha, Nebraska, United States, 68106
- Recruiting
- University of Nebraska Medical Center, Munroe-Meyer Institute
-
Contact:
- Dr. Andrea Cunha, PT, PhD
- Phone Number: 402-559-6219
- Email: abaraldicunha@unmc.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria
Children with cerebral palsy
- Aged 6 to 17
- Unilateral and bilateral cerebral palsy (Hemiplegic or Diplegic cerebral palsy)
- Manual Ability Classification System Score (MACS) between I-IV.
- Gross Motor Function Classification System (GMFCS) levels ranging from I to III.
- Ability to follow verbal instructions
Typically developing children
- Aged 6 to 17
- Good physical health
- Ability to follow verbal instructions
Exclusion Criteria
Children with cerebral palsy
- Other conditions leading to the inability to move the upper extremity or handle objects
- Visual impairments preventing the performance of intervention and testing tasks
- Received an intensive therapeutic intervention involving upper extremities, botulinum toxin in an upper extremity within the past 6 months, or any upper extremity surgery in the past year
Typically developing children
- Chronic illnesses or medical conditions that could impact their development
- Significant behavioral or emotional issues that could indicate developmental disorders or psychological conditions
- Diagnosed developmental disorders [e.g., autism, Attention-deficit/hyperactivity disorder (ADHD), learning disabilities]
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control Group
There is no intervention for this group.
Investigators will record healthy children's brain activity to train the virtual reality (VR) program to improve upper limb function.
|
|
|
Experimental: Cerebral Palsy Group
Participants in the Cerebral Palsy Group (CP) will be split into two groups of two partici[ants.
Both groups will play some VR games while hand movements are tracked.
These groups will switch after approximately 2 hours.
The two groups are Condition 1 (standard HABIT in HABIT-VR camps and HABIT-VR in BCI-HABIT-VR camps) and Condition 2 (VR HABIT in HABIT-VR camps and BCI-augmented VR HABIT in BCI-HABIT-VR camps).
|
Recent research indicates that running a camp using virtual reality (VR) software designed for a technique called hand-arm bimanual Intensive Training (HABIT) can help improve movement planning and execution in children with cerebral palsy (CP).
In this study, investigators aim to combine brain activity monitoring (known as Brain-Computer Interface Neurofeedback, or BCI-NFT) to aid the rehabilitation of upper limb movements in children with CP.
Furthermore, this new VR system (BCI-HABIT-VR) effects on brain activity and arm movement skills will be compared to the traditional HABIT-VR program.
Other Names:
Participants will engage in a virtual reality (VR) game designed to train upper limbs.
A wristband, called the Empatica E4, will be worn which will help measure various factors such as heart rate, sweat levels, and skin temperature.
Additionally, the upper limb movements during the game will be measured.
There will be no brain activity recording for this group.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assisting Hand Assessment
Time Frame: From enrollment to the training sessions over two weeks and two assessment sessions within one week before and after the treatment
|
The Assisting Hand Assessment (AHA) is scored from 0 to 100 AHA-units, with higher scores indicating greater ability in using the affected in bi-manual tasks.
|
From enrollment to the training sessions over two weeks and two assessment sessions within one week before and after the treatment
|
|
Brain Cortical Activity Measurement by Waveguard Electroencephalogram Cap
Time Frame: Baseline (first assessment session) to 2 weeks
|
Changes in a participant's brain cortical activity will be measured during the intervention using a an FDA-cleared WAVEGUARD (TM) EEG Cap and an eego amplifier.
|
Baseline (first assessment session) to 2 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Box and Block Test Time
Time Frame: From enrollment to the training sessions over two weeks and two assessment sessions within one week before and after the treatment.
|
The Box and Block Test Time (BBT) will count the number of aparticipant can transfer from one compartment of a divided box to the other within 60 seconds.
More blocks indicates better hand function.
|
From enrollment to the training sessions over two weeks and two assessment sessions within one week before and after the treatment.
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Ahad Behboodi, PhD, University of Nebraska
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0407-24-FB
- P20GM109090 (U.S. NIH Grant/Contract)
- 1R15HD117277-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.